rethinkPeptides Search
Menu
Research citation

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Endocrine oncology (Bristol, England), 4(1), e240013

Citation

Boehm, Emma; Hung, Terry; Akhurst, Tim; Alipour, Ramin; Chiang, Cherie; Hicks, Rodney J; Hofman, Michael S; Ravi Kumar, Aravind S; Sachithanandan, Nirupa; Saghebi, Javad; Michael, Michael; Kong, Grace. (2024). Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.. Endocrine oncology (Bristol, England), 4(1), e240013. https://doi.org/10.1530/EO-24-0013